For research use only. Not for therapeutic Use.
IN04 is a Novel inhibitor of LRRK1, suppressing osteoclast function, but not osteoclast differentiation.
Catalog Number | I029292 |
Synonyms | IN04; IN-04; IN 04 |
Molecular Formula | C20H19N3O6S |
Purity | 98% |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | Methyl 3-(2-((5-(3,5-dimethoxyphenyl)-1,3,4-oxadiazol-2-yl)thio)acetamido)benzoate |
InChI | InChI=1S/C20H19N3O6S/c1-26-15-8-13(9-16(10-15)27-2)18-22-23-20(29-18)30-11-17(24)21-14-6-4-5-12(7-14)19(25)28-3/h4-10H,11H2,1-3H3,(H,21,24) |
InChIKey | MCQJCSNFOKHYLJ-UHFFFAOYSA-N |
SMILES | O=C(OC)C1=CC=CC(NC(CSC2=NN=C(C3=CC(OC)=CC(OC)=C3)O2)=O)=C1 |
Reference | 1: Si M, Zeng C, Goodluck H, Shen S, Mohan S, Xing W. A small molecular inhibitor |